--- title: "Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm" type: "News" locale: "en" url: "https://longbridge.com/en/news/293651835.md" description: "Kaskela Law LLC has announced an investigation into Amneal Pharmaceuticals, Inc. (AMRX) to determine if the company or its officers violated securities laws or breached fiduciary duties regarding recent corporate actions. The firm is encouraging AMRX shareholders to contact them for information on their legal rights and options." datetime: "2026-07-23T17:44:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293651835.md) - [en](https://longbridge.com/en/news/293651835.md) - [zh-HK](https://longbridge.com/zh-HK/news/293651835.md) --- # Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm **Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm** Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether Amneal or the company’s officers and/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. **_Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 – 0750, or by email at_** **_abell@kaskelalaw.com_****_._** Investors may contact the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser) and filling out our online form: **_https://kaskelalaw.com/case/amneal/_** **ABOUT KASKELA LAW:** Kaskela Law LLC _exclusively_ represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis (_i.e._, the firm’s clients are never responsible for any out-of-pocket costs for legal representation). Since 2020, the firm has helped to recover over $500 million for investors. For additional information about Kaskela Law LLC, including the firm’s recent notable recoveries for investors, please visit www.kaskelalaw.com. This communication may constitute attorney advertising in certain jurisdictions. **KASKELA LAW LLC** D. Seamus Kaskela, Esq. (skaskela@kaskelalaw.com) Adrienne Bell, Esq. (abell@kaskelalaw.com) 18 Campus Blvd., Suite 100 Newtown Square, PA 19073 (484) 229 - 0750 www.kaskelalaw.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260723118855/en/ ### Related Stocks - [AMRX.US](https://longbridge.com/en/quote/AMRX.US.md) ## Related News & Research - [Amneal completes acquisition of Kashiv BioSciences](https://longbridge.com/en/news/295404706.md) - [Amneal Pharmaceuticals, Inc. $AMRX Shares Acquired by Bank of New York Mellon Corp](https://longbridge.com/en/news/294598892.md) - [Did Strong Q2 Results and Higher 2026 Revenue Guidance Just Shift Amneal Pharmaceuticals' (AMRX) Investment Narrative?](https://longbridge.com/en/news/294685724.md) - [Dimensional Fund Advisors LP Raises Holdings in Amneal Pharmaceuticals, Inc. $AMRX](https://longbridge.com/en/news/294576137.md) - [Amneal Pharmaceuticals (AMRX) Stock Asks If Profit Momentum Can Endure](https://longbridge.com/en/news/294562863.md)